High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation

High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Pharmaceutical Sciences - Volume 123, 15 October 2018, Pages 268-276

Adam J.R. Gadd, Valeria Castelletto, Elena Kabova, Kenneth Shankland, Yvonne Perrie, Ian Hamley, Alexander J.A. Cobb, F. Greco, Alexander D. Edwards,